Rexford Capital’s GSK GSK Stock Holding History

Rexford Capital’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$352K	Hold	6,376	–	–	0.25%	121
2025 Q4	$313K	Hold	6,376	–	–	0.24%	120
2025 Q3	$275K	Hold	6,376	–	–	0.21%	136
2025 Q2	$245K	Buy	+6,376	New	+$244K	0.2%	137

Other funds holding GSK

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Rexford Capital's GSK Position: Q1 2026 in Review

Rexford Capital held its GSK (GSK) position steady in Q1 2026 at 6,376 shares worth $352K. The position accounts for 0.25% of the portfolio, ranked #121.

Rexford Capital first reported a position in GSK in Q2 2025 and has held it in 4 quarters since. 1,032 funds tracked by Wall St. Rank hold GSK as of Q1 2026.

Rexford Capital held 6,376 shares of GSK worth $352K as of Q1 2026.
Rexford Capital left its GSK share count unchanged in Q1 2026.
GSK made up 0.25% of Rexford Capital's portfolio in Q1 2026, its #121 holding.
Rexford Capital first reported a position in GSK in Q2 2025 and has held it in 4 quarters since.
1,032 funds tracked by Wall St. Rank held GSK as of Q1 2026.

Based on Rexford Capital's 13F filing for Q1 2026, filed 24 Apr 2026.